NewAmsterdam Pharma Company N.V.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -5.3% | -5.3% | -4.7% |
| FY2023 | -61.4% | -61.4% | -51.0% |
| FY2024 | -31.9% | -31.9% | -27.9% |
| FY2025 | -29.8% | -29.8% | -26.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -5.3% | -5.3% | -4.7% |
| FY2023 | -61.4% | -61.4% | -51.0% |
| FY2024 | -31.9% | -31.9% | -27.9% |
| FY2025 | -29.8% | -29.8% | -26.5% |